Ascendis Pharma A/S (Ascendis Pharma A/S) EV-to-Revenue

Ascendis Pharma A/S Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-Revenue							407.23	969.61	797.33	124.32	25.43

Ascendis Pharma A/S Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue																124.32	72.57	40.24	33.90	25.43

For the Biotechnology subindustry, Ascendis Pharma A/S's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

For the Biotechnology industry and Healthcare sector, Ascendis Pharma A/S's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Ascendis Pharma A/S's EV-to-Revenue falls into.

Ascendis Pharma A/S EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Ascendis Pharma A/S's EV-to-Revenue for today is calculated as:

Ascendis Pharma A/S's current Enterprise Value is $8,242.8 Mil.
Ascendis Pharma A/S's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $288.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ascendis Pharma A/S  (NAS:ASND) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Ascendis Pharma A/S's PS Ratiofor today is calculated as:

Ascendis Pharma A/S's share price for today is $140.90.
Ascendis Pharma A/S's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.12.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ascendis Pharma A/S EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Ascendis Pharma A/S's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascendis Pharma A/S (Ascendis Pharma A/S) Business Description